Skip to main content
Fig. 6 | BMC Cancer

Fig. 6

From: Overweight with HBV infection limited the efficacy of TACE in hepatocellular carcinoma by inhibiting the upregulated HMGB1

Fig. 6

Subgroup analysis of blood samples results according to different population. The concentration analysis results of relevant indicators of HMGB1 in blood samples were compared and analyzed based on the group and time. HMGB1 = high-mobility group protein 1; RAGE = receptor for advanced glycation endproducts; TNF-α = tumor necrosis factor-α; VEGF = vascular endothelial growth factor

Back to article page